Interim Reports. The Parties shall exchange formal written interim progress reports on a schedule agreed to by the PIs, but at least within twelve (12) months after this CRADA becomes effective and at least within every twelve (12) months thereafter. Such reports shall set forth the technical progress made, identifying such problems as may have been encountered and establishing goals and objectives requiring further effort, any modifications to the Research Plan pursuant to Article 3.2, and identify Subject Inventions pursuant to Article 6.1.
Appears in 5 contracts
Sources: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement (Newlink Genetics Corp), Cooperative Research and Development Agreement
Interim Reports. The Parties shall exchange formal written interim progress reports on a schedule agreed to by the PIs, but at least within twelve (12) months after this CRADA becomes effective and at least within every twelve (12) months thereafter. Such reports shall set forth the technical progress made, identifying such problems as may have been encountered and establishing goals and objectives requiring further effort, any modifications to the Research Plan pursuant to Article 3.2, and identify Subject Inventions pursuant to Article 6.1all CRADA-related patent applications filed.
Appears in 4 contracts
Sources: Cooperative Research and Development Agreement (Paracelsian Inc /De/), Cooperative Research and Development Agreement (Sequenom Inc), Cooperative Research and Development Agreement (Sequenom Inc)
Interim Reports. The Parties shall exchange formal written interim progress reports on a schedule agreed to by the PIs, but at least within twelve six (126) months after this CRADA becomes effective and at least within every twelve six (126) months thereafter. Such reports shall set forth the technical progress made, identifying such problems as may have been encountered and establishing goals and objectives requiring further effort, any modifications to the Research Plan pursuant to Article 3.2, and identify Subject Inventions pursuant to Article 6.1.
Appears in 2 contracts
Sources: Cooperative Research and Development Agreement (Progenics Pharmaceuticals Inc), Cooperative Research and Development Agreement (Progenics Pharmaceuticals Inc)
Interim Reports. The Parties shall exchange formal written interim progress reports report on a schedule agreed to by the PIs, but at least within twelve (12) months after this CRADA becomes effective and at least within every twelve (12) months thereafter. Such reports shall set forth the technical progress made, identifying such problems as may have been encountered and establishing goals and objectives requiring further effort, any modifications to the Research Plan pursuant to Article 3.2, and identify Subject Inventions pursuant to Article 6.1all CRADA-related patent applications filed.
Appears in 1 contract
Sources: Cooperative Research and Development Agreement (Keryx Biopharmaceuticals Inc)
Interim Reports. The Parties shall exchange formal written interim progress reports on a schedule agreed to by the PIs, but at least within twelve (12) months after this CRADA becomes effective and at least within every twelve (12) months thereafter. Such reports shall set forth the technical progress made, identifying such problems as may have been ben encountered and establishing goals and objectives requiring further effort, any modifications to the Research Plan pursuant to Article 3.2, and identify Subject Inventions pursuant to Article 6.1all CRADA-related patent applications filed.
Appears in 1 contract
Sources: Cooperative Research and Development Agreement (Neopharm Inc)
Interim Reports. The Parties shall exchange formal written interim progress reports on a schedule agreed to by the PIsPI, but at least within twelve (12) six months after this CRADA becomes effective and at least within every twelve (12) six months thereafter. Such reports repots shall set forth the technical progress made, identifying such problems as may have been encountered and establishing goals and objectives requiring further effort, any modifications to the Research Plan pursuant to Article 3.2, and identify Subject Inventions pursuant to Article 6.1all CRADA-related patent applications filed.
Appears in 1 contract